The compound hasn't been subjected on the rigorous clinical testing required for acceptance by regulatory bodies including the FDA, which implies its basic safety and success in treating medical conditions continue to be unproven. When comparing conolidine with common analgesics, dissimilarities in security profiles and side effects crop up. https://epicurusv721ncm6.blogoscience.com/profile